Crestline Management, LP Ionis Pharmaceuticals Inc Transaction History

Crestline Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $919,776 - $1.15 Million	-21,450 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$40.53 - $50.7 $166,294 - $208,022	-4,103 Reduced 16.06%	21,450 $894,000
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $1,190 - $1,486	27 Added 0.11%	25,553 $1.13 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $1.28 Million - $1.64 Million	-25,431 Reduced 49.91%	25,526 $1.28 Million
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $2.32 Million - $3.04 Million	50,957	50,957 $2.58 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.